The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis
Top Cited Papers
- 19 August 2008
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 105 (33) , 11945-11950
- https://doi.org/10.1073/pnas.0711697105
Abstract
The persistence of Mycobacterium tuberculosis despite prolonged chemotherapy represents a major obstacle for the control of tuberculosis. The mechanisms used by Mtb to persist in a quiescent state are largely unknown. Chemical genetic and genetic approaches were used here to study the physiology of hypoxic nonreplicating mycobacteria. We found that the intracellular concentration of ATP is five to six times lower in hypoxic nonreplicating Mtb cells compared with aerobic replicating bacteria, making them exquisitely sensitive to any further depletion. We show that de novo ATP synthesis is essential for the viability of hypoxic nonreplicating mycobacteria, requiring the cytoplasmic membrane to be fully energized. In addition, the anaerobic electron transport chain was demonstrated to be necessary for the generation of the protonmotive force. Surprisingly, the alternate ndh-2, but not -1, was shown to be the electron donor to the electron transport chain and to be essential to replenish the [NAD(+)] pool in hypoxic nonreplicating Mtb. Finally, we describe here the high bactericidal activity of the F(0)F(1) ATP synthase inhibitor R207910 on hypoxic nonreplicating bacteria, supporting the potential of this drug candidate for shortening the time of tuberculosis therapy.Keywords
This publication has 40 references indexed in Scilit:
- Diarylquinolines target subunit c of mycobacterial ATP synthaseNature Chemical Biology, 2007
- Synergistic Activity of R207910 Combined with Pyrazinamide against Murine TuberculosisAntimicrobial Agents and Chemotherapy, 2007
- Altered NADH/NAD + Ratio Mediates Coresistance to Isoniazid and Ethionamide in MycobacteriaAntimicrobial Agents and Chemotherapy, 2005
- Shortening the treatment of tuberculosisNature Biotechnology, 2005
- New Insights into Type II NAD(P)H:Quinone OxidoreductasesMicrobiology and Molecular Biology Reviews, 2004
- Transcriptional Adaptation of Mycobacterium tuberculosis within MacrophagesThe Journal of Experimental Medicine, 2003
- Susceptibility of Mycobacterium tuberculosis to weak acidsJournal of Antimicrobial Chemotherapy, 2003
- Enhanced gene replacement in mycobacteriaMicrobiology, 1999
- Requirement for the Proton‐Pumping NADH Dehydrogenase I of Escherichia Coli in Respiration of NADH to Fumarate and Its Bioenergetic ImplicationsEuropean Journal of Biochemistry, 1997
- Enzyme systems in the micobacteria VII. Purification, properties and mechanism of action of the alanine dehydrogenaseBiochimica et Biophysica Acta, 1959